These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36484260)

  • 1. Novel Cardiokine GDF3 Predicts Adverse Fibrotic Remodeling After Myocardial Infarction.
    Masurkar N; Bouvet M; Logeart D; Jouve C; Dramé F; Claude O; Roux M; Delacroix C; Bergerot D; Mercadier JJ; Sirol M; Gellen B; Livrozet M; Fayol A; Robidel E; Trégouët DA; Marazzi G; Sassoon D; Valente M; Hulot JS
    Circulation; 2023 Feb; 147(6):498-511. PubMed ID: 36484260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrogenic Potential of PW1/Peg3 Expressing Cardiac Stem Cells.
    Yaniz-Galende E; Roux M; Nadaud S; Mougenot N; Bouvet M; Claude O; Lebreton G; Blanc C; Pinet F; Atassi F; Perret C; Dierick F; Dussaud S; Leprince P; Trégouët DA; Marazzi G; Sassoon D; Hulot JS
    J Am Coll Cardiol; 2017 Aug; 70(6):728-741. PubMed ID: 28774379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectonucleoside triphosphate diphosphohydrolase-1 (CD39) impacts TGF-β1 responses: insights into cardiac fibrosis and function following myocardial infarction.
    Novitskaya T; Nishat S; Covarrubias R; Wheeler DG; Chepurko E; Bermeo-Blanco O; Xu Z; Baer B; He H; Moore SN; Dwyer KM; Cowan PJ; Su YR; Absi TS; Schoenecker J; Bellan LM; Koch WJ; Bansal S; Feoktistov I; Robson SC; Gao E; Gumina RJ
    Am J Physiol Heart Circ Physiol; 2022 Dec; 323(6):H1244-H1261. PubMed ID: 36240436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
    Lian R; Chen Y; Xu Z; Zhang X
    Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Fibroblast-Specific Activating Transcription Factor 3 Promotes Myocardial Repair after Myocardial Infarction.
    Li YL; Hao WJ; Chen BY; Chen J; Li GQ
    Chin Med J (Engl); 2018 Oct; 131(19):2302-2309. PubMed ID: 30246716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise attenuates inflammation and limits scar thinning after myocardial infarction in mice.
    Puhl SL; Müller A; Wagner M; Devaux Y; Böhm M; Wagner DR; Maack C
    Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H345-59. PubMed ID: 26001415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tropoelastin Improves Post-Infarct Cardiac Function.
    Hume RD; Kanagalingam S; Deshmukh T; Chen S; Mithieux SM; Rashid FN; Roohani I; Lu J; Doan T; Graham D; Clayton ZE; Slaughter E; Kizana E; Stempien-Otero AS; Brown P; Thomas L; Weiss AS; Chong JJH
    Circ Res; 2023 Jan; 132(1):72-86. PubMed ID: 36453283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA-Mediated Suppression of a Cardioprotective Cardiokine as a Novel Mechanism Exacerbating Post-MI Remodeling by Sleep Breathing Disorders.
    Du Y; Wang X; Li L; Hao W; Zhang H; Li Y; Qin Y; Nie S; Christopher TA; Lopez BL; Lau WB; Wang Y; Ma XL; Wei Y
    Circ Res; 2020 Jan; 126(2):212-228. PubMed ID: 31694459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction.
    Karwi QG; Zhang L; Wagg CS; Wang W; Ghandi M; Thai D; Yan H; Ussher JR; Oudit GY; Lopaschuk GD
    Cardiovasc Diabetol; 2019 Jan; 18(1):1. PubMed ID: 30626440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1.
    Noppe G; Dufeys C; Buchlin P; Marquet N; Castanares-Zapatero D; Balteau M; Hermida N; Bouzin C; Esfahani H; Viollet B; Bertrand L; Balligand JL; Vanoverschelde JL; Beauloye C; Horman S
    J Mol Cell Cardiol; 2014 Sep; 74():32-43. PubMed ID: 24805196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNAP is a novel regulator of cardiac fibrosis after myocardial infarction by mediating TGF-β/Smads and ERK1/2 signaling pathways.
    Cheng X; Wang L; Wen X; Gao L; Li G; Chang G; Qin S; Zhang D
    EBioMedicine; 2021 May; 67():103370. PubMed ID: 33971401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infiltrated cardiac lipids impair myofibroblast-induced healing of the myocardial scar post-myocardial infarction.
    Vilahur G; Casani L; Juan-Babot O; Guerra JM; Badimon L
    Atherosclerosis; 2012 Oct; 224(2):368-76. PubMed ID: 22882904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of Cx43 attenuates ventricular remodeling after myocardial infarction via impaired TGF-beta signaling.
    Zhang Y; Wang H; Kovacs A; Kanter EM; Yamada KA
    Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H477-87. PubMed ID: 19966054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-activated receptor 1 inhibition by SCH79797 attenuates left ventricular remodeling and profibrotic activities of cardiac fibroblasts.
    Sonin DL; Wakatsuki T; Routhu KV; Harmann LM; Petersen M; Meyer J; Strande JL
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):460-75. PubMed ID: 23598708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts.
    Kishore R; Verma SK; Mackie AR; Vaughan EE; Abramova TV; Aiko I; Krishnamurthy P
    PLoS One; 2013; 8(4):e60161. PubMed ID: 23560074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MK5 haplodeficiency decreases collagen deposition and scar size during post-myocardial infarction wound repair.
    Nawaito SA; Sahadevan P; Clavet-Lanthier MÉ; Pouliot P; Sahmi F; Shi Y; Gillis MA; Lesage F; Gaestel M; Sirois MG; Calderone A; Tardif JC; Allen BG
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1281-H1296. PubMed ID: 30901279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting 5-HT
    Snider JC; Riley LA; Mallory NT; Bersi MR; Umbarkar P; Gautam R; Zhang Q; Mahadevan-Jansen A; Hatzopoulos AK; Maroteaux L; Lal H; Merryman WD
    Circulation; 2021 Mar; 143(13):1317-1330. PubMed ID: 33474971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remote Zone Extracellular Volume and Left Ventricular Remodeling in Survivors of ST-Elevation Myocardial Infarction.
    Carberry J; Carrick D; Haig C; Rauhalammi SM; Ahmed N; Mordi I; McEntegart M; Petrie MC; Eteiba H; Hood S; Watkins S; Lindsay M; Davie A; Mahrous A; Ford I; Sattar N; Welsh P; Radjenovic A; Oldroyd KG; Berry C
    Hypertension; 2016 Aug; 68(2):385-91. PubMed ID: 27354423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretome Analysis of Cardiomyocytes Identifies PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6) as a Novel Player in Cardiac Remodeling After Myocardial Infarction.
    Kuhn TC; Knobel J; Burkert-Rettenmaier S; Li X; Meyer IS; Jungmann A; Sicklinger F; Backs J; Lasitschka F; Müller OJ; Katus HA; Krijgsveld J; Leuschner F
    Circulation; 2020 May; 141(20):1628-1644. PubMed ID: 32100557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of BTK ameliorates the pathological cardiac fibrosis and dysfunction.
    Wang B; Tan Y; Zhou W; Yang J; Jiang Y; Liu X; Zhan Z
    Matrix Biol; 2022 Sep; 112():171-189. PubMed ID: 36031013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.